Patient Compliance

Optimizing care in patients with community-acquired pneumonia.

New products, new indications, and recent clinical developments.

The pharmacist’s role in the genomic evolution.

Ontario government proposes regulatory amendments to limit access to the drug.

Health Canada reviewing European recommendations that restrict use of calcitonin because of evidence suggesting an increased risk of cancer.

Frontotemporal dementia

Categories traditionally targeted at seniors can get a boost when products are tailored to a wider market.

Seeking answers to high-cost drug dilemmas.

Pharmacists should focus greater attention on adherence to therapy within the first month of statin treatment, study suggests.